Holen Sie sich die Stockscreener-App
32.98
0.52%
0.17
Vorhandelsmarkt:
33.01
0.03
+0.09%
Schlusskurs vom Vortag:
$32.81
Offen:
$32.84
24-Stunden-Volumen:
8.20M
Relative Volume:
1.28
Marktkapitalisierung:
$16.22B
Einnahmen:
$194.78B
Nettoeinkommen (Verlust:
$-6.68B
KGV:
-2.4211
EPS:
-13.6221
Netto-Cashflow:
$4.32B
1W Leistung:
-5.61%
1M Leistung:
-22.16%
6M Leistung:
-4.82%
1J Leistung:
-44.42%
1-Tages-Spanne:
$32.06
$32.98
1-Wochen-Bereich:
$32.06
$37.05
52-Wochen-Spanne:
$25.07
$66.03
Centene Corp Stock (CNC) Company Profile
Firmenname
Centene Corp
Sektor
Branche
Telefon
(314) 725-4477
Adresse
7700 FORSYTH BLVD., ST LOUIS
Compare CNC vs UNH, CVS, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
32.98 | 16.22B | 194.78B | -6.68B | 4.32B | -13.62 |
UNH
Unitedhealth Group Inc
|
272.28 | 247.14B | 447.57B | 12.81B | 16.08B | 13.19 |
CVS
Cvs Health Corp
|
72.80 | 92.62B | 402.11B | 1.73B | 7.81B | 1.3835 |
CI
Cigna Group
|
265.87 | 70.10B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
290.33 | 64.08B | 199.13B | 5.66B | 3.17B | 25.11 |
HUM
Humana Inc
|
172.23 | 20.68B | 129.66B | 1.20B | 375.00M | 9.8083 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-07-28 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-07-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-07-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-07-02 | Herabstufung | UBS | Buy → Neutral |
| 2025-06-09 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-04-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2025-02-06 | Herabstufung | Argus | Buy → Hold |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-13 | Hochstufung | UBS | Neutral → Buy |
| 2024-12-10 | Herabstufung | Jefferies | Hold → Underperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-03-21 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-09-05 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-06-20 | Eingeleitet | UBS | Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-30 | Eingeleitet | Argus | Buy |
| 2022-08-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-28 | Fortgesetzt | Barclays | Overweight |
| 2022-07-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-21 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Fortgesetzt | Bernstein | Outperform |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-07 | Fortgesetzt | Barclays | Overweight |
| 2022-01-06 | Fortgesetzt | JP Morgan | Overweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-13 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-12-13 | Bestätigt | BofA Securities | Buy |
| 2021-12-13 | Bestätigt | Credit Suisse | Neutral |
| 2021-12-13 | Bestätigt | Mizuho | Neutral |
| 2021-12-13 | Bestätigt | Oppenheimer | Outperform |
| 2021-12-13 | Bestätigt | Stephens | Overweight |
| 2021-12-13 | Bestätigt | Truist | Buy |
| 2021-12-13 | Bestätigt | Wells Fargo | Overweight |
| 2021-12-13 | Bestätigt | Wolfe Research | Outperform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-10 | Eingeleitet | Mizuho | Neutral |
| 2021-01-21 | Fortgesetzt | Goldman | Neutral |
| 2021-01-15 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-02-03 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-01-28 | Bestätigt | Bernstein | Outperform |
| 2020-01-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-10-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-07-18 | Fortgesetzt | Citigroup | Neutral |
| 2017-12-18 | Bestätigt | Jefferies | Buy |
| 2017-09-13 | Bestätigt | Leerink Partners | Mkt Perform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2017-02-08 | Bestätigt | Barclays | Overweight |
| 2017-02-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-01-04 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Centene Corp Aktie (CNC) Neueste Nachrichten
Centene Corp. stock under pressure from Medicaid redeterminations and rising medical costs in Q1 202 - AD HOC NEWS
Centene Corporation Form 8-K Filing Summary for March 18, 2026 – Company Details, Stock Listing, and Compliance Information - Minichart
Centene appoints Theodore Pienkos as chief accounting officer and controller - Investing.com
Centene Corp stock faces Medicaid redetermination pressures amid 2026 policy shifts - AD HOC NEWS
Theodore Pienkos named Corporate Controller & Chief Accounting Officer at Centene; Kate Casso moves to SVP, Finance Operations and Innovation - TradingView
Centene Corp. stock faces pressure amid Medicaid redeterminations and rising medical costs in Q1 202 - AD HOC NEWS
Chamber Decries ‘Catch-22' of Centene Worker’s 401(k) Lawsuit - Bloomberg Law News
Centene Corp. stock faces analyst pressure amid healthcare sector headwinds and mixed forecasts - AD HOC NEWS
Centene Corp. stock underperforms Friday when compared to competitors - MarketWatch
Centene Corp. Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators - Markets Mojo
CNC Stock Price, Quote & Chart | CENTENE CORP (NYSE:CNC) - ChartMill
Centene Corp. stock underperforms Thursday when compared to competitors - MarketWatch
JP Morgan Lowers Price Target for CNC, Maintains Neutral Rating | CNC Stock News - GuruFocus
Centene, Paramount Skydance, and Ulta Beauty are among top 10 large cap losers last week (March 9-March 13): Are the others in your portfolio? - MSN
Insight Wealth Strategies LLC Acquires Shares of 121,559 Centene Corporation $CNC - MarketBeat
Centene Corp (CNC) Stock Price, Trades & News - GuruFocus
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
Centene CEO: My stressful schedule wasn't actually making me better at my job—how she avoids burnout today - MSN
WellCare of Kentucky Launches Food Is Medicine Program in Eastern Kentucky to Tackle Growing Diabetes Rates - Finviz
Centene Corp. Stock (ISIN: US15133V1035) Hits Multi-Year Lows Amid Profitability Pressures and Mixed - AD HOC NEWS
CNC Invests $4.4M to Enhance Community Services in LA County - GuruFocus
Centene Corp. Stock Falls 40% as Q4 Earnings Miss and 2026 Guidance Crumbles—Is the Rebound Real? - AD HOC NEWS
Centene, Paramount Skydance, And Ulta Beauty Are Among Top 10 Large Cap Losers Last Week (March 9-March 13): Are the Others in Your Portfolio? - Sahm
Centene Corp. Stock Hits Day Low of $36.27 Amid Price Pressure - Markets Mojo
Centene's 0.90% Rally Defies 429th-Ranked Trading Volume as Institutional Cash Inflows Surge 700% in Q3 - Bitget
Why Medicaid insurers are optimistic even as massive cuts loom - Modern Healthcare
Centene, Paramount Skydance, And Ulta Beauty Are Among Top 10 Large Cap Losers Last Week (March 9-March 13): Are the Others in Your Portfolio? - Benzinga
Centene (CNC) Leads Healthcare Losers with 21% Drop - GuruFocus
Clearline Capital LP Raises Stock Holdings in Centene Corporation $CNC - MarketBeat
One Big Beautiful Bill Act: A Boon or Bane for Centene? - MSN
Centene Corp. Stock (ISIN: US15133V1035) Faces Pressure Amid Institutional Buying and Analyst Cautio - AD HOC NEWS
What’s News in Markets: Campbell’s Snack Problem, Centene Sinks, Petco Optimism - WSJ
Quinn Opportunity Partners LLC Has $5.39 Million Position in Centene Corporation $CNC - MarketBeat
Centene Confronts ACA Membership Slide And Tests AI Driven Cost Controls - Yahoo Finance
Centene (CNC) Valuation Check After Barclays Conference Selloff And ACA Marketplace Concerns - simplywall.st
Bernstein SocGen cuts Centene stock price target on 4Q results By Investing.com - Investing.com Canada
Bernstein SocGen cuts Centene stock price target on 4Q results - Investing.com Australia
Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana and Centene - The Globe and Mail
Zacks Industry Outlook Features UnitedHealth, The Cigna, Humana, and Centene - Bitget
US insurers and hospitals turn to new AI for age-old battle over charges vs payments - Reuters
Obamacare’s Slow Death Is Debilitating Centene Stock - Barchart.com
Mizuho Maintains Neutral Stance, Lowers Price Target on CNC | CN - GuruFocus
Centene (CNC) Shares Drop Over 10% - GuruFocus
Oracle, Nio, Centene, AeroVironment And Ciena Corporation: Why These 5 Stocks Are On Investors' Radars Today - Sahm
Mizuho cuts Centene stock price target on exchange enrollment concerns By Investing.com - Investing.com Australia
Centene (CNC) Shares Plummet Amid ACA Challenges - GuruFocus
Is Centene Stock Underperforming the Nasdaq? - Barchart.com
Centene tumbles on ACA warnings but leads managed care with top Buy Quant rating (CNC:NYSE) - Seeking Alpha
Mizuho cuts Centene stock price target on exchange enrollment concerns - Investing.com Nigeria
Why Is Centene Stock Falling On Tuesday? - Bitget
U.S. Indexes Finished Mixed Tuesday As BridgeBio Pharma Led, Centene Lagged - Barron's
Finanzdaten der Centene Corp-Aktie (CNC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.23%
1.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):